Clinical trial
Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
NCT00366509 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00366509 |
|---|---|
| Title | Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases |
| Official title | Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Pulmonary Disease, Oropharyngeal Disease, Lymphangioleiomyomatosis, Pulmonary Fibrosis, Asthma, Sarcoidosis |
| Enrollment | 157 |
| Start date | Sep 18, 2006 |
| Primary completion | Jan 1, 2016 |
| Completion | Oct 27, 2016 |
| First posted | Aug 21, 2006 |
| Last update posted | Aug 2, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: